Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

10.72
-0.3600-3.25%
Volume:398.50K
Turnover:4.31M
Market Cap:2.35B
PE:-7.58
High:11.05
Open:11.01
Low:10.70
Close:11.08
52wk High:16.44
52wk Low:6.23
Shares:218.91M
Float Shares:185.00M
Volume Ratio:0.26
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4140
EPS(LYR):-1.4203
ROE:-72.99%
ROA:-34.95%
PB:4.51
PE(LYR):-7.55

Loading ...

Analyst Reiterates Buy Rating on OCUL, Keeps Axpaxli-Driven Price Target Unchanged at $18

TIPRANKS
·
May 06

Stock Track | Ocular Therapeutix Plummets 6.86% Intraday After Q1 Earnings Miss Estimates

Stock Track
·
May 06

Stock Track | Ocular Therapeutix Plunges 6.45% in Pre-Market After Q1 Earnings Miss Estimates

Stock Track
·
May 05

Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)

TIPRANKS
·
May 05

Earnings Flash (OCUL) Ocular Therapeutix Posts Q1 Loss $0.40 a Share, vs. FactSet Est of $0.31 Loss

MT Newswires Live
·
May 05

Ocular Therapeutix Q1 EPS $(0.40) Misses $(0.33) Estimate, Sales $10.785M Miss $12.599M Estimate

Benzinga Earnings
·
May 05

Ocular Therapeutix Inc - Cash and Cash Equivalents of $666.7 Mln as of March 31, 2026,Expected Runway Into 2028

THOMSON REUTERS
·
May 05

Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights

GlobeNewswire
·
May 05

What Ocular Therapeutix (OCUL)'s SOL-X Long-Term AXPAXLI Extension Study Means For Shareholders

Simply Wall St.
·
May 02

Ocular Therapeutix announces annual shareholder meeting

Reuters
·
May 01

Ocular Therapeutix (OCUL) Receives a Buy from William Blair

TIPRANKS
·
Apr 29

Ocular Therapeutix enrolls first patient in Axpali trial

TIPRANKS
·
Apr 29

Ocular Therapeutix enrolls first patient in SOL-X AXPAXLI wet AMD extension trial

Reuters
·
Apr 29

Ocular Therapeutix™ Announces First Patient Enrolled in Sol-X Long-Term Extension Trial for Axpaxli™ in Wet Amd

THOMSON REUTERS
·
Apr 29

Ocular Therapeutix to report first-quarter results, host conference call and webcast

Reuters
·
Apr 28

Ocular Therapeutix to present at Bank of America Health Care Conference fireside chat

Reuters
·
Apr 27

Assessing Ocular Therapeutix (OCUL) Valuation As AXPAXLI Prospects Drive A Wide Gap To Fair Value Estimates

Simply Wall St.
·
Apr 22

Ocular Therapeutix to host investor day webcast

Reuters
·
Apr 22

Ocular Therapeutix grants inducement equity awards to new hires under 2019 plan

Reuters
·
Apr 14

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 14